We are delighted to announce that the Hep C Drug Treatment Provider Forum has been selected as the winner of the Best Healthcare Analytics Project for the NHS at the HSJ Partnership Awards 2023.
The Hep C Drug Treatment Provider Forum is a partnership of drug treatment providers, which includes Humankind, hosted by Gilead pharmaceuticals to collectively promote and manage hepatitis C provision among drug services nationally. The partnership’s ultimate aim is to work together to eliminate hepatitis C and the award has recognised its outstanding dedication to improving healthcare and effective collaboration with the NHS. Other partners include The Hepatitis C Trust, NHS England, NHS Addiction Providers Alliance, Change Grow Live, Forward Trust, Turning Point, WDP, and We Are With You.
Winners in a total of 21 outstanding categories, were announced during a ceremony at Evolution London, on 23 March 2023, hosted by comedian, Joel Dommett. Over 900 guests attended the event, bringing together national healthcare leaders and professionals from the NHS, public and private sectors. A total of 141 finalists were celebrated on the evening.
The Health & Care Act cites collaboration and partnership working as the key success factor for the future sustainability of the NHS. The HSJ Partnerships Awards are therefore not just a celebration of success stories but also a platform to shape the future of our integrated health and care system.
The prestigious award programme, now in its sixth year, recognises and honours the most effective partnerships, innovative projects and collaborations in the UK health system. A light has been shone on The Hep C Drug Treatment Provider forum and Humankind’s role in strengthening the healthcare system through the Award.
The judging panel was comprised of a diverse range of highly regarded figures across the NHS and wider healthcare sector.
Deborah Moores, national hep C coordinator at Humankind, said: “Together, national hep C coordinators have worked tirelessly to boost testing numbers far above levels prior to the pandemic and refused to take their feet off the gas to keep things moving.”
“Recording accurately to reflect activity is always a challenge but by working together with a consistent approach. Four criteria were set to determine elimination, and a data system was created to be able to monitor progress against the agreed criteria. We now have accurate data that we can cross reference with other data streams and use to support services towards the goal of elimination.
“Winning the HSJ award for our work with data analytics has been the icing on the cake and will help to drive all services towards the elimination finish line. It is a true privilege to work with such a passionate group of individuals who are all working in competition every day but as one with the hep C elimination strategy.”
HSJ editor Alastair McLellan said: “The national healthcare sector faced innumerable pressures over the past 12 months, yet the standard and overriding positivity of the partnerships yet again this year highlights the enduring dedication to improving patient outcomes. So, we’re delighted that the Hep C Drug Treatment Provider Forum has been announced as winners in the category of Best Healthcare Analytics Project for the NHS at this year’s HSJ Partnership Awards 2023.
“The partnership stood out in an outstanding field of nominees, each showcasing the very best collaborations and innovations in the healthcare sector today. Well done – all credit to you and your team – you can be proud of all that you’ve achieved.”
The winners were selected following a rigorous two-stage judging process by a group of 90 judges ahead of the HSJ Partnership Awards 2023 awards ceremony. The full list of Winners and those Highly Commended for the 2023 HSJ Partnership Awards can be found at https://partnership.hsj.co.uk/winners-2023.
